- Home
- INSP vs ARWR Comparison
INSP vs ARWR Comparison
Compare INSP & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSP
- ARWR
- Stock Information
- Founded
- INSP 2007
- ARWR 2003
- Country
- INSP United States
- ARWR United States
- Employees
- INSP N/A
- ARWR N/A
- Industry
- INSP Medical/Dental Instruments
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- INSP Health Care
- ARWR Health Care
- Exchange
- INSP Nasdaq
- ARWR Nasdaq
- Market Cap
- INSP 5.6B
- ARWR 2.4B
- IPO Year
- INSP 2018
- ARWR 1993
- Fundamental
- Price
- INSP $170.17
- ARWR $18.05
- Analyst Decision
- INSP Buy
- ARWR Buy
- Analyst Count
- INSP 11
- ARWR 11
- Target Price
- INSP $232.55
- ARWR $43.33
- AVG Volume (30 Days)
- INSP 603.8K
- ARWR 1.4M
- Earning Date
- INSP 02-10-2025
- ARWR 02-04-2025
- Dividend Yield
- INSP N/A
- ARWR N/A
- EPS Growth
- INSP N/A
- ARWR N/A
- EPS
- INSP 1.09
- ARWR N/A
- Revenue
- INSP $755,594,000.00
- ARWR $3,551,000.00
- Revenue This Year
- INSP $29.96
- ARWR $3,402.96
- Revenue Next Year
- INSP $19.49
- ARWR $123.96
- P/E Ratio
- INSP $155.26
- ARWR N/A
- Revenue Growth
- INSP 32.52
- ARWR N/A
- 52 Week Low
- INSP $123.00
- ARWR $17.05
- 52 Week High
- INSP $257.40
- ARWR $36.72
- Technical
- Relative Strength Index (RSI)
- INSP 36.14
- ARWR 36.67
- Support Level
- INSP $185.03
- ARWR $17.75
- Resistance Level
- INSP $216.01
- ARWR $20.78
- Average True Range (ATR)
- INSP 8.57
- ARWR 1.03
- MACD
- INSP -1.46
- ARWR -0.11
- Stochastic Oscillator
- INSP 3.04
- ARWR 9.90
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.